For most men these pills are close to magic. For a sizeable minority, they do nothing at all—and that fact is usually met with embarrassment, a suspicion that the pill is fake, or a quiet decision to give up. None of those is the right response. The roughly one-in-three men who don't respond are not a mystery. Their non-response is one of the most useful signals in all of male medicine, because it maps precisely onto how the drug actually works, and onto what is actually wrong.

An amplifier, not a generator

The key to the whole thing is this: a PDE5 inhibitor is an amplifier, not a generator. It cannot conjure an erection out of nothing. It can only make louder a signal the body is already sending. Arousal dispatches a nitric-oxide signal to the penis, the vessels relax, and blood flows in; the drug's entire job is to keep that signal from fading too fast. Turn up an amplifier with no input and all you get is louder silence.

That single fact explains both the high success rate and the predictable failures. Across studies, these drugs work for around 70% of men—which means roughly a third don't get an adequate response. That gap is rarely the drug being defective. It almost always traces to one of four understandable situations.

One: the wires are cut

The arousal signal has to travel down nerves that release nitric oxide right at the erectile tissue. If those nerves are damaged, the signal never arrives, and there is nothing for the drug to prolong. The textbook case is after radical prostate surgery—the erectile nerves run directly alongside the prostate, and an initial failure to respond is almost universal, sometimes for two to three years while the nerves slowly recover, if they do. Advanced diabetes does something similar by injuring small nerves throughout the body. Where there is no nerve signal at all, the pills show essentially no benefit—exactly what you'd expect from an amplifier with its input cable cut.

Two: the pipes are too narrow

Even with a perfect signal, the arteries have to be able to widen and deliver the blood. In severe atherosclerosis the vessels are too stiff and furred-up to open, no matter how loud the relaxation signal becomes. (This is also why erectile dysfunction can be an early warning of wider artery disease—but here the point is the ceiling it places on treatment.) An amplifier can boost a signal; it cannot unblock a pipe.

Three: the volume knob is missing

Testosterone quietly maintains the machinery. It even governs how much of the nitric-oxide and PDE5 apparatus the penile tissue builds, and it underpins desire itself. When testosterone is low, there may be little arousal signal to amplify in the first place, and the pills can work poorly until the hormone is corrected. Sometimes the fix isn't a louder amplifier but restoring the input—though that takes weeks to months to take effect, not minutes.

Four: user error — the most common of all

Here's the genuine surprise. The single most common reason the pills "fail" is none of the above—it's that they were used incorrectly. The pill does nothing without real arousal. It needs time to take effect. A heavy, fatty meal can blunt or delay the shorter-acting ones. The dose may simply be too low. And many men abandon the drug after one or two attempts when several are often needed. Study after study finds that a large share of so-called non-responders begin responding once a clinician corrects the dose, the timing, and the expectations. Performance anxiety can drown the signal too—the one place the mind re-enters the story—but it's a smaller slice than most people assume.

What to do when the pill doesn't work

Real, confirmed non-response is a reason to see a doctor, not to escalate to ever-bigger doses from questionable sources. The options are logical once you see the mechanism: optimize the dose and timing, switch to a different PDE5 inhibitor or a daily regimen, correct a low testosterone, treat the vascular risk factors—and when the pills genuinely can't work because the nerves or vessels are too damaged, move to treatments that act downstream of them entirely, such as injections that relax the erectile tissue directly, vacuum devices, or a surgical implant. The limits of the mechanism write the menu.

It's worth being clear about one tempting shortcut. Reaching for a different format of the same drug—say, swapping a tablet for an unregulated Cialis Sublingual tadalafil tablet in the hope of a stronger hit—changes how fast the drug arrives, not whether there's a signal for it to amplify. If a standard dose isn't working, a faster or unverified version of the identical molecule won't address the underlying reason, and at an unknown strength it adds risk of its own.

The bigger picture

There is something almost honest about a drug that can't perform miracles. A PDE5 inhibitor's failures aren't malfunctions—they're a precise readout of the parts of the system it was never able to touch. Which means that understanding why a pill doesn't work for a particular man is often the fastest route to understanding what is actually wrong, and what would help.

Most of medicine, in the end, isn't about forcing the body to do something new. It's about helping it do, a little better, what it was already trying to do—and noticing, when that fails, what has gone quiet.

References

1. PDE5 inhibitor efficacy is roughly 70%, with about a third of men failing to respond; the most common cause of initial failure is inadequate patient education or unoptimized dosing, alongside severe penile vascular disease, unrecognized hypogonadism, comorbidities and vascular risk factors, and psychosocial factors; initial failure is almost universal after radical prostatectomy (Medicine Today, 2020; "Treatment Strategy for Non-Responders to PDE5 Inhibitors," PMC).
2. Nerve damage from radical prostatectomy (cavernous-nerve injury) and diabetes reduces or eliminates PDE5-inhibitor response; recovery may take 24–36 months, with little benefit where erectile nerves are not preserved (review and meta-analysis literature).
3. Testosterone regulates PDE5 expression and penile vasodilator mechanisms; low testosterone limits PDE5-inhibitor efficacy, and its correction can "salvage" some non-responders over a period of weeks (Expert Opinion on Pharmacotherapy, 2015).
4. Second- and third-line options for confirmed non-responders include intracavernosal injection therapy (acting downstream on erectile smooth muscle), vacuum erection devices, and penile prosthesis (review literature).

This article is for general educational purposes and is not medical advice. Tadalafil is a prescription medicine, and persistent erectile dysfunction can signal an underlying condition worth evaluating; always consult a qualified healthcare professional.